MEDIFAST INC Sees Q1 2024 EPS $0.25-$0.95 Vs $1.50 Est.l Revenue $155M-$175M Vs $205.786M Est.
Portfolio Pulse from Benzinga Newsdesk
MEDIFAST INC projects its Q1 2024 earnings per share (EPS) to be between $0.25 and $0.95, significantly below the estimated $1.50. The company also forecasts revenue to range from $155 million to $175 million, which is lower than the expected $205.786 million.

February 20, 2024 | 9:42 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
MEDIFAST INC anticipates a significant decrease in its Q1 2024 EPS and revenue, falling well below analysts' expectations.
The projected decrease in both EPS and revenue for MEDIFAST INC is substantial when compared to analyst estimates. This discrepancy is likely to negatively impact investor sentiment and could lead to a decrease in the stock price in the short term. The significant gap between the company's forecasts and analysts' expectations suggests a potential underlying issue that could affect the company's financial health or market position.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100